Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Dermatomyositis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 522 Leukemia, Myeloid, Acute 493 Carcinoma, Non-Small-Cell Lung 377 Neoplasms 376 Pancreatic Neoplasms 324 Precursor Cell Lymphoblastic Leukemia-Lymphoma 317 Multiple Myeloma 309 Melanoma 309 Glioblastoma 306 Prostatic Neoplasms 292 Leukemia 288 Neoplasm Metastasis 282 Brain Neoplasms 274 Lymphoma 270 Lung Neoplasms 268 Recurrence 266 Ovarian Neoplasms 247 Colorectal Neoplasms 243 Lymphoma, Non-Hodgkin 241 Leukemia, Lymphocytic, Chronic, B-Cell 231 Myelodysplastic Syndromes 207 Glioma 207 Lymphoma, Large B-Cell, Diffuse 185 Carcinoma, Hepatocellular 172 Lymphoma, Follicular 167 Hodgkin Disease 160 Head and Neck Neoplasms 160 Lymphoma, Mantle-Cell 155 Burkitt Lymphoma 153 Sarcoma 151

Interventions

Sodium Chloride 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed

16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡